Education
About Us
Working with TipRanks
Follow Us
Everest Medicines Ltd. (HK:1952)
:1952
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 706.68M | ¥ 125.93M | ¥ 12.79M | ¥ 54.00K | ¥ 0.00 |
| Gross Profit | ¥ 528.89M | ¥ 91.52M | ¥ 8.15M | ¥ 31.00K | ¥ 0.00 |
| Operating Income | ¥ -1.12B | ¥ -932.74M | ¥ -256.80M | ¥ -1.03B | ¥ -688.46M |
| EBITDA | ¥ -670.04M | ¥ -744.63M | ¥ -198.91M | ¥ -972.78M | ¥ -683.03M |
| Net Income | ¥ -1.04B | ¥ -844.46M | ¥ -247.28M | ¥ -1.01B | ¥ -5.68B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.60B | ¥ 2.35B | ¥ 1.65B | ¥ 2.64B | ¥ 4.48B |
| Total Assets | ¥ 4.96B | ¥ 5.77B | ¥ 6.61B | ¥ 6.65B | ¥ 7.48B |
| Total Debt | ¥ 575.61M | ¥ 510.63M | ¥ 534.64M | ¥ 485.03M | ¥ 447.33M |
| Net Debt | ¥ -308.86M | ¥ -12.44M | ¥ 12.93M | ¥ -2.16B | ¥ -4.03B |
| Total Liabilities | ¥ 886.05M | ¥ 804.10M | ¥ 960.25M | ¥ 753.83M | ¥ 636.11M |
| Stockholders' Equity | ¥ 4.07B | ¥ 4.97B | ¥ 5.65B | ¥ 5.89B | ¥ 6.84B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -744.92M | ¥ -1.04B | ¥ -1.59B | ¥ -1.71B | ¥ -991.83M |
| Operating Cash Flow | ¥ -679.51M | ¥ -769.19M | ¥ -1.16B | ¥ -729.94M | ¥ -471.90M |
| Investing Cash Flow | ¥ 974.40M | ¥ 752.50M | ¥ -1.03B | ¥ -975.82M | ¥ -519.93M |
| Financing Cash Flow | ¥ 37.80M | ¥ 10.10M | ¥ -25.31M | ¥ -76.51M | ¥ 5.64B |